US 7,321,002 B2
Chiral integrin modulators and methods of use thereof
John B. Davidson, Chicago, Ill. (US); Alexander V. Tatarintsev, Moscow (Russian Federation); Ali S. Turgiev, Moscow (Russian Federation); and James K. Hildreth, Woodstock, Md. (US)
Assigned to Billings Pharmaceuticals, Inc., Chicago, Ill. (US)
Filed on May 15, 2006, as Appl. No. 11/434,037.
Application 11/434037 is a continuation of application No. 10/332545, granted, now 7,045,663, previously published as PCT/US01/21826, filed on Jul. 10, 2001.
Claims priority of provisional application 60/217651, filed on Jul. 10, 2000.
Prior Publication US 2006/0205824 A1, Sep. 14, 2006
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/105 (2006.01); A61K 31/10 (2006.01); C07C 321/00 (2006.01)
U.S. Cl. 514—707  [514/708; 568/22] 50 Claims
 
1. A pharmaceutical composition comprising a pharmaceutically-acceptable carrier and Z(−)-4,5,9-trithiadodeca-1,6,11-triene-9-oxide.